Search
Filter Results
- Resource Type
- Article1
- Journal1
- Journal Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Arzneimittelforschung1
Search Results
Sort by
- ArticleShibata Y.Arzneimittelforschung. 1977;27(12):2299-308.4'-Chloro-5-methoxy-3-biphenylylacetic acid (DKA-9) is a novel phenylacetic acid derivative with marked anti-inflammatory, analgesic and antipyretic activities. DKA-9 was approximately 2 times and 25 times more effective than ibuprofen in inhibiting carrageenin-induced paw edema and adjuvant-induced arthritis, respectively, in rats. The anti-inflammatory effect of DKA-9 was observed also in adrenalectomized rats. In the Randall-Selitto test in rats, DKA-9 was about 2 times more potent than ibuprofen and equipotent to indometacin. In lowering brewer's yeast-induced fever in rats, DKA-9 was almost 1/2 times more effective than ibuprofen. Considering from therapeutic index (ED50 in ulcerogenic effect/ED50 in carrageenin-induced edema), DKA-9 was found to be much superior to indometacin or ibuprofen.